1. Academic Validation
  2. Astragaloside IV mediates radiation-induced neuronal damage through activation of BDNF-TrkB signaling

Astragaloside IV mediates radiation-induced neuronal damage through activation of BDNF-TrkB signaling

  • Phytomedicine. 2024 Jun 8:132:155803. doi: 10.1016/j.phymed.2024.155803.
Xin Liu 1 Yanping Ding 2 Chenxin Jiang 1 Yuanyuan Xin 1 Xin Ma 1 Min Xu 1 Qianhao Wang 1 Boru Hou 3 Yingdong Li 4 Shengxiang Zhang 1 Baoping Shao 5
Affiliations

Affiliations

  • 1 School of Life Sciences, Lanzhou University, Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, Lanzhou 730000, Gansu Province, PR China.
  • 2 School of Life Sciences, Northwest Normal University, Lanzhou 730070, Gansu Province, PR China.
  • 3 Department of Neurosurgery, Second Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, PR China.
  • 4 School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, PR China.
  • 5 School of Life Sciences, Lanzhou University, Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, Lanzhou 730000, Gansu Province, PR China. Electronic address: shaobp@lzu.edu.cn.
Abstract

Background: Electromagnetic radiation is relevant to human life, and radiation can trigger neurodegenerative diseases by altering the function of the central nervous system through oxidative stress, mitochondrial dysfunction, and protein degradation. Astragaloside IV (AS-IV) is anti-oxidative, anti-apoptotic, activates the BDNF-TrkB pathway and enhances synaptic plasticity in radiated mice, which can exert its neuroprotection. However, the exact molecular mechanisms are still unclear.

Purpose: This study investigated whether AS-IV could play a neuroprotective role by regulating BDNF-TrkB pathway in radiation damage and its underlying molecular mechanisms.

Methods: Transgenic mice (Thy1-YFP line H) were injected with AS-IV (40 mg/kg/day body weight) by intraperitoneal injection daily for 4 weeks, followed by X-rays. PC12 cells and primary cortical neurons were also exposed to UVA after 24 h of AS-IV treatment (25 μg/ml and 50 μg/ml) in vitro. The impact of radiation on learning and cognitive functions was visualized in the Morris water maze assay. Subsequently, Immunofluorescence and Golgi-Cox staining analyses were utilized to investigate the structural damage of neuronal dendrites and the density of dendritic spines. Transmission electron microscopy was performed to examine how the radiation affected the ultrastructure of neurons. Finally, western blotting analysis and Quantitative RT-PCR were used to evaluate the expression levels and locations of proteins in vitro and in vivo.

Results: Radiation induced BDNF-TrkB signaling dysregulation and decreased the levels of neuron-related functional genes (Ngf, Bdnf, Gap-43, Ras, Psd-95, Arc, Creb, c-Fos), PSD-95 and F-actin, which subsequently led to damage of neuronal ultrastructure and dendrites, loss of dendritic spines, and decreased dendritic complexity index, contributing to spatial learning and memory deficits. These abnormalities were prevented by AS-IV treatment. In addition, TrkB receptor antagonists antagonized these neuroprotective actions of AS-IV. 7,8-dihydroxyflavone and AS-IV had neuroprotective effects after radiation.

Conclusion: AS-IV inhibits morphological damage of neurons and cognitive dysfunction in mice after radiation exposure, resulting in a neuroprotective effect, which were mediated by activating the BDNF-TrkB pathway.

Keywords

Astragaloside IV; BDNF-TrkB signaling pathway; Neuronal damage; Radiation.

Figures
Products